Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
Glioblastoma (GBM) is an extremely aggressive brain tumor. Its standard treatment currently involves surgery followed by radiotherapy and temozolomide. However, recurrence is frequently unavoidable, and the effect of various treatments is not ideal due to numerous inherent obstacles. Immunotherapy h...
Saved in:
| Main Authors: | Yuanyang Sun, Yun Wang, Shukun Mu, Xiaofeng Wu, Suchun Yu, Zhongming Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1523675/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis
by: Zhaoming Song, et al.
Published: (2025-12-01) -
Immunotherapy in Glioblastoma: An Overview of Current Status
by: Sarfraz Z, et al.
Published: (2025-07-01) -
Advances in Cellular Immune Theranostic Approaches for Glioblastoma: Current Trends and Future Directions
by: Ying Gong, et al.
Published: (2025-08-01) -
Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment
by: Dongxin Jiang, et al.
Published: (2025-05-01) -
PTEN as a prognostic factor for radiotherapy plus immunotherapy response in nasopharyngeal carcinoma
by: Jiaxing Guo, et al.
Published: (2025-04-01)